Cytokinetics' hopes of resurrecting cardiac myosin activator omecamtiv mecarbil have suffered another setback, after the drug failed to show a benefit in a phase 3 heart failure study. In the ...

Explaining his reasoning, the medic says: 'Certain chemotherapy medications can affect your heart, can cause heart failure, [and] can cause breathing problems. '[It] makes sense cause ...

Consult a healthcare provider before changing your medication or taking new medicines ... sodium you need depends on factors ...

In the first 22 months of a mavacamten REMS program, few patients needed a temporary interruption in treatment for LVEF below 50%.

New analysis from GlobalData spans the growth of the heart failure market across seven major markets including the US, Europe ...

Delivering drug therapy for advanced CHF is best achieved within the setting of a multiprofessional heart failure team. The end stage of advanced CHF is characterized by multiple symptomatologies ...

Said Watt, “Using stem cells from patients with heart failure caused by chemo, we are actively developing new drugs and cell-based treatments that we believe will transform the lives of patients ...

A recent study from Columbia University has raised important questions about the medications used to treat high blood ...

Rosiglitazone, a drug from the thiazolidinedione class, has been used to help control blood sugar levels in people with type ...

“People with both elevated [heart failure] risk and obesity might receive extra benefit from weight-lowering medications ... failure] and identifying best treatment practices.” ...